The revenue stands at ₹4,336.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 4.00 per cent from ₹4,516.60 crore. This corresponds to a year-on-year *(YoY) growth of 10.00 per cent.
Operating Profit stands at ₹833.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.30 per cent from ₹939.90 crore. This corresponds to a year-on-year *(YoY) growth of 11.32 per cent.
PBDT stands at ₹675.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.29 per cent from ₹760.90 crore. This corresponds to a year-on-year *(YoY) growth of 22.30 per cent.
Profit Before Tax stands at ₹127.60 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 48.44 per cent from ₹247.50 crore. This corresponds to a year-on-year *(YoY) growth of 31.68 per cent.
Net Profit stands at ₹136.80 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 31.12 per cent from ₹198.60 crore. This represents a 53.36 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Biocon | 0.66% | 1.72% | -5.48% | -8.02% | 5.50% | 7.07% |
| Mankind Pharma | -0.64% | 0.63% | -3.03% | -9.22% | 19.80% | -11.29% |
| Glenmark Pharma. | 1.97% | 2.19% | 1.69% | 10.84% | 16.27% | 20.48% |
| Alkem Lab | -1.67% | 4.94% | 1.06% | 0.81% | 5.13% | -1.57% |
| Abbott India | -0.48% | 3.82% | 2.75% | 4.10% | 6.57% | -10.15% |
| Anthem Bioscienc | 0.77% | -0.16% | 6.51% | 22.81% | 49.69% | 13.35% |
| Ipca Labs. | 0.04% | 4.01% | 4.71% | 25.87% | 31.25% | 43.87% |
Chairperson : Kiran Mazumdar Shaw
Non-Exec & Non-Independent Dir : Ravi Mazumdar
Non-Exec & Non-Independent Dir : Eric Vivek Mazumdar
Lead Independent Director : Naina Lal Kidwai
Independent Non Exe. Director : Rekha Mehrotra Menon
Independent Non Exe. Director : NICHOLAS ROBERT HAGGAR
Independent Non Exe. Director : Atul Dhawan
Managing Director & CEO : Shreehas Pradeep Tambe
Company Sec. & Compli. Officer : RAJESH UMAKANT SHANOY